![Helga Rübsamen-Schaeff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helga Rübsamen-Schaeff
Directeur/Membre du Conseil chez
4SC AG
Profil
Helga Rübsamen-Schaeff is the founder of AiCuris GmbH & Co. KG, founded in 2006, where the title held was Managing Director from 2006 to 2015.
Dr. Rübsamen-Schaeff is the founder of Aicuris Anti-Infective Cures AG, founded in 2006, holding the title Member-Supervisory Board currently.
Current jobs include Chairman-Supervisory Board at Merck Healthcare KGaA; Member-Supervisory Board at Merck KGaA since 2014; Member-Supervisory Board at 4SC AG since 2015; Professor at Johann Wolfgang Goethe-Universität Frankfurt am Main since 1988; Member-Supervisory Board at Universitätsklinikum Bonn; Partner at E.
Merck KG; Member at Deutsche Akademie der Naturforscher Leopoldina eV; Member-Supervisory Board at Merck Life Science KGaA; and Member at Deutsche Akademie der Technikwissenschaften eV since 2022.
Former jobs include Scientific & Executive Director at Chemotherapeutic Research Institute Georg-Speyer-Haus from 1987 to 1993; Managing Director at Georg Speyer Haus from 1987 to 1993; SVP & Global Head-Anti Infective Research at Bayer HealthCare AG from 2001 to 2006; and Senior VP & Head-Antiinfectives Research at Bayer AG from 2001 to 2006.
Education includes an undergraduate degree conferred in 1971 and a doctorate conferred in 1973, both from the University of Münster.
Postes actifs de Helga Rübsamen-Schaeff
| Sociétés | Poste | Début |
|---|---|---|
| MERCK KGAA | Directeur/Membre du Conseil | 09/05/2014 |
| 4SC AG | Directeur/Membre du Conseil | 02/01/2015 |
Universitätsklinikum Bonn | Directeur/Membre du Conseil | - |
Merck Life Science KGaA | Directeur/Membre du Conseil | - |
Merck Healthcare KGaA
 Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Président | - |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of anti viral therapeutics | Fondateur | 01/01/2006 |
Deutsche Akademie der Naturforscher Leopoldina eV | Corporate Officer/Principal | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1988 |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical preparations | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Helga Rübsamen-Schaeff
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Helga Rübsamen-Schaeff
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AiCuris GmbH & Co. KG
 AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for antiviral and antibacterial agents | Commercial Services |
Chemotherapeutic Research Institute Georg-Speyer-Haus
 Chemotherapeutic Research Institute Georg-Speyer-Haus Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Universitätsklinikum Bonn | |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical preparations | Health Technology |
Deutsche Akademie der Naturforscher Leopoldina eV | |
Deutsche Akademie der Technikwissenschaften eV
 Deutsche Akademie der Technikwissenschaften eV Miscellaneous Commercial ServicesCommercial Services Engages in advising on technical and technological issues for engineering and applied sciences | Commercial Services |
Georg Speyer Haus | |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of anti viral therapeutics | Commercial Services |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Health Technology |
Merck Life Science KGaA |
